Published in Gastroenterology on September 01, 1995
Helicobacter pylori persistence: biology and disease. J Clin Invest (2004) 4.75
Does Helicobacter pylori protect against asthma and allergy? Gut (2008) 2.67
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06
The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut (2001) 2.02
The clinical relevance of strain types of Helicobacter pylori. Gut (1997) 1.99
Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut (1998) 1.82
Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28
Corpus gastritis is protective against reflux oesophagitis. Gut (1999) 1.23
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. Gut (1999) 1.15
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut (1997) 1.13
Precise role of H pylori in duodenal ulceration. World J Gastroenterol (2006) 1.11
Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol (2001) 1.04
Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients. World J Gastroenterol (2005) 1.04
Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem (2008) 1.04
Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun (2003) 1.02
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer (2011) 1.00
Pattern-recognition receptors and gastric cancer. Front Immunol (2014) 0.95
Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem (2007) 0.95
Helicobacter pylori, gastric acid, and duodenal gastric metaplasia. Gut (1996) 0.95
Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut (2002) 0.94
Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine. Front Immunol (2013) 0.91
Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol (2006) 0.91
Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench (2015) 0.91
Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview. World J Gastroenterol (2000) 0.91
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89
Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci (2011) 0.88
Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. World J Surg (2003) 0.88
Gastric hypersecretion associated to iodoacetamide-induced mild gastritis in mice. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.87
Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin Diagn Lab Immunol (2003) 0.86
Toll-like receptor 2 (TLR) -196 to 174del polymorphism in gastro-duodenal diseases in Japanese population. Dig Dis Sci (2007) 0.86
Helicobacter pylori modulation of gastric acid. Yale J Biol Med (2000) 0.86
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). J Gastroenterol (2007) 0.86
In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86
Expression of progastrin-derived peptides and somatostatin in fundus and antrum of nonulcer dyspepsia subjects with and without Helicobacter pylori infection. Dig Dis Sci (2000) 0.85
Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Dig Dis Sci (2007) 0.85
Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention. Heart Vessels (2012) 0.85
Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"? World J Gastroenterol (2013) 0.84
Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect Immun (2000) 0.84
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. BMC Gastroenterol (2010) 0.84
Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut (1998) 0.83
Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation. Gut (1999) 0.83
Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci (2005) 0.83
Environmental - lifestyle related factors. Best Pract Res Clin Gastroenterol (2010) 0.83
Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients. J Gastroenterol (2012) 0.82
Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol (2005) 0.82
Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection. Dig Dis Sci (2006) 0.82
Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. Gut (1998) 0.82
Does Helicobacter pylori infection contribute to gastroesophageal reflux disease? Yale J Biol Med (1999) 0.82
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer. Gut (1998) 0.82
Helicobacter pylori infection in sickle cell disease. J Natl Med Assoc (2000) 0.82
Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells. Ann Gastroenterol (2012) 0.81
pH, healing rate and symptom relief in acid-related diseases. Yale J Biol Med (1997) 0.81
Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase. Gut (2001) 0.81
Bisphosphonate increases risk of gastroduodenal ulcer in rheumatoid arthritis patients on long-term nonsteroidal antiinflammatory drug therapy. J Gastroenterol (2009) 0.81
Helicobacter pylori and functional dyspepsia: an unsolved issue? World J Gastroenterol (2014) 0.81
Potential relevance of agmatine as a virulence factor of Helicobacter pylori. Dig Dis Sci (1999) 0.81
Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. Dig Dis Sci (2001) 0.81
Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol (2009) 0.81
Neutrophil-derived hydroxyl radicals mediate interleukin-8-induced increases in tetragastrin-stimulated acid secretion in rats. Dig Dis Sci (2003) 0.80
Protective effect of ammonia against reflux esophagitis in rats. Dig Dis Sci (2001) 0.80
Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol (2015) 0.80
Endoscopic grading of atrophic gastritis is inversely associated with gastroesophageal reflux and gastropharyngeal reflux. Korean J Intern Med (2007) 0.80
Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. J Physiol (1997) 0.79
Genetic determinants and clinico-pathological outcomes of helicobacter pylori infection. Ann Ib Postgrad Med (2014) 0.78
Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus. Dig Dis Sci (2007) 0.78
Redefining the role of surgery for perforated duodenal ulcer in the Helicobacter pylori era. Ann Surg (2000) 0.78
Gastrin-releasing peptide, acid secretion, Helicobacter pylori, and duodenal ulcer: another epiphenomenon? Gastroenterology (1996) 0.77
Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? J Neurogastroenterol Motil (2010) 0.77
Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection. Dig Dis Sci (2001) 0.77
Helicobacter pylori and gastro-oesophageal reflux disease: information underlying pathology is not given. BMJ (2004) 0.77
Long-term effects of Helicobacter pylori infection on acid and pepsin secretion. Yale J Biol Med (1997) 0.77
Influence of MDR1 polymorphism on H. pylori-related chronic gastritis. Dig Dis Sci (2010) 0.77
No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci (2001) 0.77
Presence of minimal change esophagitis closely correlates with pathological conditions in the stomach. Dig Dis Sci (2011) 0.77
Chemical Composition of the Essential Oil of Mastic Gum and their Antibacterial Activity Against Drug-Resistant Helicobacter pylori. Nat Prod Bioprospect (2014) 0.76
H. pylori infection is related to mitochondrial microsatellite instability in gastric carcinogenesis. Infect Agent Cancer (2016) 0.76
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. Dig Dis Sci (1998) 0.76
Helicobacter pylori Infection: Options for Testing and Treatment. Gastroenterol Hepatol (N Y) (2012) 0.75
A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication. PLoS One (2016) 0.75
Pharmacotherapy for acid/peptic disorders. Yale J Biol Med (1997) 0.75
Pathobiology of Helicobacter pylori infection. Yale J Biol Med (1999) 0.75
CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2. Cell Microbiol (2015) 0.75
Interleukin-1B 31 C>T polymorphism combined with Helicobacter pylori-modified gastric cancer susceptibility: evidence from 37 studies. J Cell Mol Med (2016) 0.75
Helicobacter pylori does not release cysteamine into gastric juice. J Clin Pathol (1997) 0.75
Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia. Dig Dis Sci (2001) 0.75
Impairment of gastric secretion modulation in duodenal ulcer and in long-term PPI treatment: quantitative morphologic findings and pathophysiologic implications. Dig Dis Sci (2001) 0.75
Effect of interleukin-8 on histamine release from totally isolated vascularly perfused rat stomach. J Gastroenterol (2005) 0.75
Bile acid reflux and possible inhibition of Helicobacter pylori infection in subjects without gastric surgery. Dig Dis Sci (2001) 0.75
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Dig Dis Sci (2003) 0.75
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
Alosetron in irritable bowel syndrome. Lancet (2000) 2.94
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 2.89
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology (1999) 2.53
Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut (1999) 2.28
The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol (1996) 2.19
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut (1993) 2.05
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology (2000) 1.74
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet (1989) 1.70
Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut (1991) 1.66
Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J (2005) 1.66
EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc (2000) 1.64
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut (1993) 1.64
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut (2008) 1.53
Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology (1994) 1.50
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut (1999) 1.50
Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol (1998) 1.45
Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988. Q J Med (1991) 1.39
Comment on article by Oksüzoglu et al. Endoscopy (1998) 1.37
Comparison of gastric body and antral pH: a 24 hour ambulatory study in healthy volunteers. Gut (1989) 1.33
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology (2000) 1.33
Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut (1991) 1.31
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Neuroendocrine tumors. A European view. Am J Med (1986) 1.29
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut (1994) 1.28
A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut (1993) 1.27
Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol Med Microbiol (1996) 1.26
Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut (1989) 1.23
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut (1994) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc (2001) 1.17
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects. Scand J Gastroenterol (1992) 1.14
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. Aliment Pharmacol Ther (2009) 1.13
Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut (1991) 1.13
Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology (1996) 1.12
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology (1998) 1.12
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 1.10
Endoscopic ultrasonography in the diagnosis and management of suspected upper gastrointestinal submucosal tumours. Br J Surg (2002) 1.09
The porphyrias: an example of pharmacogenetic disease. Scott Med J (1981) 1.09
Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol (1997) 1.08
Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06
A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut (1995) 1.05
Editorial: chronic liver disease and deaths from peptic ulcer bleeding. Aliment Pharmacol Ther (2015) 1.05
A combined TDDA-PVC pH and reference electrode for use in the upper small intestine. J Med Eng Technol (1990) 1.04
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol (1993) 1.04
Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology (1999) 1.03
Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut (1991) 1.02
Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol (1992) 1.01
Comparison of helisal rapid blood test and 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol (1998) 0.99
Effect of rifampicin on haem and bilirubin metabolism in man. Br J Clin Pharmacol (1987) 0.98
Measurement of urea and ammonium concentrations in gastric juice. J Clin Pathol (1993) 0.96
Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium. J Clin Pathol (1991) 0.95
Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. Arch Dis Child (2000) 0.93
Does diabetes affect outcome after arthroscopic repair of the rotator cuff? J Bone Joint Surg Br (2010) 0.92
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) (1982) 0.92
Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest (1980) 0.92
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation. Scand J Gastroenterol (1992) 0.91
An assessment of the potential value of endoscopic ultrasound as a cost-minimizing tool in dyspeptic patients with persistent symptoms. Endoscopy (2001) 0.91
In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand J Gastroenterol (2002) 0.91
Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut (1992) 0.90
Early-onset chronic renal failure as a complication of acute intermittent porphyria. Q J Med (1983) 0.90
The acute porphyrias. Br J Clin Pract (1993) 0.89
Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al. Arthritis Rheum (1998) 0.89
Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril. Int J Clin Pharmacol Res (1985) 0.88
Smoking and recurrent attacks of acute intermittent porphyria. BMJ (1991) 0.88
Problems associated with the clinical use of proton pump inhibitors. Pharmacol Toxicol (2001) 0.87
The use of adalimumab in the management of refractory Crohn's disease. Aliment Pharmacol Ther (2007) 0.87
Gastric corpus atrophy following eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol (2001) 0.86
Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet (1985) 0.86
Age dependent hypergastrinaemia in children with Helicobacter pylori gastritis--evidence of early acquisition of infection. Gut (1995) 0.86
Helicobacter pylori in the faeces? QJM (1999) 0.86
Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol (1991) 0.86
Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses. BMJ (1999) 0.85
Alcohol and porphyria. Lancet (1981) 0.85
Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scand J Gastroenterol (2000) 0.84
The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women. Acta Endocrinol (Copenh) (1986) 0.84